BioStrand Omics Analysis Blog:
Genetic research

What is a biomarker?

Dr Ingrid Brands, General Manager | November 2, 2022

A biomarker, or biological marker, broadly refers to a range of objectively, accurately, and...

Precision drugs for the precision medicine era

Dr Ingrid Brands, General Manager | October 26, 2022

Currently, chemotherapy, using cytotoxic small molecules to kill cancer cells, is the predominant...

What is precision medicine?

Dr Ingrid Brands, General Manager | October 12, 2022

In 1999, an innovative collaboration between 10 of the world’s largest pharmaceutical companies,...

The role of NGS in breast cancer diagnosis and treatment

Dr Ingrid Brands, General Manager | October 6, 2022

Breast cancer is the most common cancer in women worldwide, accounting for 25% of all female...

Top 4 challenges of equitable precision medicine

Dr Ingrid Brands, General Manager | August 25, 2022

In our previous articles on precision medicine, we reviewed how advances in precision medicine...

Subscribe to our blog

The BioStrand Interviews: Meet Christophe Van Neste

BioStrand | March 23, 2022

Bioengineer, philosopher, programmer, bioinformatician and teacher, Christophe Van Neste is a truly...

How to characterise protein domains

Dr Ingrid Brands, General Manager | December 8, 2021

Classifying genes and assigning functions to gene products is a fundamental step in converting huge...

Bring Meaning to the Chaotic Space of Omics & Text

Dr Ingrid Brands, General Manager | November 11, 2021

Learn how to integrate and normalise omics and biomedical text data into a single data model/frame...

Defining next-generation biobanks

Dr Ingrid Brands, General Manager | October 27, 2021

Since the term was first introduced in the mid-nineties, biobanking has evolved significantly from...

The metadata challenge in biological research

Dr Ingrid Brands, General Manager | October 12, 2021

One of the key highlights of the global response to COVID-19 has been the importance of effective,...

Learnings from the global response to the pandemic

Dr Ingrid Brands, General Manager | September 30, 2021

Prior to 2020, the fastest vaccine development program had taken four years from viral sampling to...